Clinical Trials Directory

Trials / Sponsors / Nanjing Immunophage Biotech Co., Ltd

Nanjing Immunophage Biotech Co., Ltd

Industry · 8 registered clinical trials — 5 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingEfficacy and Safety of IPG11406 in Moderately to Severely Active Ulcerative Colitis (Phase 2)
Moderately to Severely Active Ulcerative Colitis (UC)
Phase 22026-07-07
Not Yet RecruitingIPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors
Advanced Solid Tumor
Phase 1 / Phase 22026-05-15
RecruitingPhase IIa Study for IPG11406 in Patients With Lupus Nephritis
Lupus Nephritis
Phase 1 / Phase 22025-02-25
RecruitingPhase I/II Study of IPG1094 in Advanced Solid Tumors Patients
Solid Tumor
Phase 1 / Phase 22024-07-11
CompletedPhase 1 Study for IPG11406 in Health Volunteer
Inflammatory Bowel Diseases
Phase 12024-02-24
TerminatedA Study of Orally Administered IPG7236 in Healthy Adult Participants
Atopic Dermatitis
Phase 12022-04-07
RecruitingPhase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
Safety Issues, Tolerability, Pharmacokinetics
Phase 1 / Phase 22021-11-15
UnknownStudy of IPG1094 in Healthy Participants
Safety Issues
Phase 12021-09-27